CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,717,676 | +5.6% | 431,693 | +17.0% | 6.33% | +52.1% |
| Q2 2023 | $12,039,814 | -17.3% | 369,093 | -10.8% | 4.16% | -25.1% |
| Q1 2023 | $14,561,376 | +78797.8% | 413,793 | +2.7% | 5.56% | -6.8% |
| Q4 2022 | $18,456 | -99.9% | 402,793 | +5.8% | 5.97% | -1.7% |
| Q3 2022 | $18,449,000 | +11.9% | 380,793 | -9.2% | 6.07% | +6.5% |
| Q2 2022 | $16,480,000 | – | 419,433 | – | 5.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |